Año:
2017
CiteScore:
4,900
| Categoría | Posición | Cuartil | Tercil | Decil |
|---|---|---|---|---|
| Oncology | 113/334 | Q2 | T2 | D4 |
SJR año:
2017
Factor de Impacto:
1,942
| Categoría | Posición | Cuartil | Tercil | Decil |
|---|---|---|---|---|
| Oncology | 56/388 | Q1 | T1 | D2 |
| Agencia | Código de Proyecto |
|---|---|
| Bogart Pediatric Cancer Research Program | - |
| Concern Foundation | - |
| National Institutes of Health | CA81403; U01 CA70903; CA60104; CA02649; CA14089; CA94233; CA192656; FD004385 |
| Nautica Malibu Triathlon Fund | - |
| T.J. Martell Foundation for Leukemia, Cancer and AIDS Research | - |
| # | Autor | Afiliación |
|---|---|---|
| 1 | University of Southern California; Children's Hospital Los Angeles (USA) | |
| 2 | Singh, AR | University of California System (USA) |
| 3 | Joshi, S | University of California System (USA) |
| 4 | Vega, FM | Universidad de Sevilla; Consejo Superior de Investigaciones Cientificas (CSIC); University of California System (USA) |
| 5 | Guo, PZ | University of Southern California; Children's Hospital Los Angeles (USA) |
| 6 | Xu, JY | University of Southern California; Children's Hospital Los Angeles (USA) |
| 7 | Groshen, S | Keck Sch Med (USA) |
| 8 | Ye, W | Keck Sch Med (USA) |
| 9 | Millard, M | University of Southern California; Children's Hospital Los Angeles (USA) |
| 10 | Campan, M | University of Southern California (USA) |
| 11 | Morales, G | SignalRx Pharmaceut (USA) |
| 12 | Garlich, JR | SignalRx Pharmaceut (USA) |
| 13 | Laird, PW | University of Southern California; Van Andel Institute (USA) |
| 14 | Seeger, RC | University of Southern California; Children's Hospital Los Angeles (USA) |
| 15 | Shimada, H | University of Southern California; Children's Hospital Los Angeles (USA) |
| 16 | University of California System; SignalRx Pharmaceut; Rady Childrens Hospital San Diego (USA) |
